PSA Today Dec 3: Tariff talk trouble / Astellas to buy Audentes / Minebea-Mitsumi at 14-month high on Switch / Freee prices its IPO - Nikkei -0.64%
Japan Market Comment by Pelham Smithers, William Nestuk and Lindsay WhippNikkei ¥23,379.81 (-¥149.69 / -0.64%); Topix ¥1,706.73 (-¥7.76 / -0.45%); ¥/$109.19
Tags: Nintendo (7974 JT), Tencent (700 HK), Sony (6758 JT), Square Enix (9684 JT), Colopl (3668 JT), Freee (4478 JT), Sansan (4443 JT), Cybozu (4776 JT), Astellas (4503 JT), Eisai (4523 JT), Audentes Therapeutics (BOLD US), Novartis (NOVN US), AveXis (AVXS US), Shionogi (4507 JT), Otsuka Holdings (4578 JT), Minebea Mitsumi (6479 JT), Nidec (6594 JT), Heroz (4382 JT), PKSHA (3993 JT), LINE Corp (3938 JT), Recruit (6098 JT), Microsoft (MSFT US), Orix Corp (8591 JT), Obic Business Consultant (4733 JT), Money Forward (unl.), Salesforce (CRM US)
Main Points
• US tariff talk sends market lower
• Astellas to acquire Audentes
• Minebea-Mitsumi closes at 14-month high on Switch fever
• Freee prices Dec 17 IPO
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.